Kevin Shannon

20.0k total citations · 3 hit papers
276 papers, 12.5k citations indexed

About

Kevin Shannon is a scholar working on Molecular Biology, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kevin Shannon has authored 276 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Molecular Biology, 110 papers in Hematology and 59 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kevin Shannon's work include Acute Myeloid Leukemia Research (68 papers), Cardiac Arrhythmias and Treatments (50 papers) and Chronic Myeloid Leukemia Treatments (33 papers). Kevin Shannon is often cited by papers focused on Acute Myeloid Leukemia Research (68 papers), Cardiac Arrhythmias and Treatments (50 papers) and Chronic Myeloid Leukemia Treatments (33 papers). Kevin Shannon collaborates with scholars based in United States, Canada and Germany. Kevin Shannon's co-authors include Gideon Bollag, Suzanne Schubbert, Benjamin S. Braun, Robert W. Frenck, Elizabeth H. Blackburn, Tyler Jacks, Scott C. Kogan, Patricia Thompson, Brigit R. Taylor and Frank McCormick and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Kevin Shannon

267 papers receiving 12.2k citations

Hit Papers

Hyperactive Ras in developmental disorders and cancer 1998 2026 2007 2016 2007 1998 2006 250 500 750 1000

Peers

Kevin Shannon
Comparison fields: 5 of 148
  • Molecular Biology 6.2k
  • Hematology 3.7k
  • Oncology 2.2k
  • Genetics 1.7k
  • Immunology 1.6k
Replace R.J. Arceci with:
R.J. Arceci United States
Charlotte M. Niemeyer Germany
Mineo Kurokawa Japan
Yuzuru Kanakura Japan
Katherine A. Hajjar United States
Nobuyuki Miyasaka Japan
Arndt Borkhardt Germany
Daniel A. Lawrence United States
Edo Vellenga Netherlands
Lars Kjeldsen Denmark
R.J. Arceci United States View profile →
Citations per field, relative to Kevin Shannon
Kevin Shannon · 1×
Citations per year, relative to Kevin Shannon
Kevin Shannon · 1×

Countries citing papers authored by Kevin Shannon

Since Specialization
Citations

This map shows the geographic impact of Kevin Shannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Shannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Shannon more than expected).

Fields of papers citing papers by Kevin Shannon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Shannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Shannon. The network helps show where Kevin Shannon may publish in the future.

Co-authorship network of co-authors of Kevin Shannon

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Shannon. A scholar is included among the top collaborators of Kevin Shannon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Shannon. Kevin Shannon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 2
3 1
4 4
5 82
6 8
7 16
8 2
9 24
10 44
11 11
12 4
13 47
14 123
15 24
16 33
17 6
18
Preliminary report of an ascending dose study of gemtuzumab ozogamicin (mylotarg™, cma-676) in pediatric patients with acute myeloid leukemia
10
19 73
20 72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026